BSECompany Update2 Sept 2026 · 2 Sept 2026, 02:39 pm

AS ATTACHED

JITF Infralogistics Ltd · 540311

✦ AI SummaryMgmt Change

JITF Infralogistics Ltd has announced the appointment of Dr. Vinita Jha as an Additional Director and the resignation of Ms. Kanika Sharma as a Non-Executive Director, effective September 2, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern5/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

JITF Infralogistics Ltd - 540311 - Announcement under Regulation 30 (LODR)-Change in Management

Attachments (1)

📄

1f545f2d-05d1-4708-8236-76992a579a6d.pdf

pdf

Download →
View document text
Date: 02.09.2026 BSE Limited National Stock Exchange Limited Corporate Relation Department Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street Bandra(E) Mumbai- 400001 Mumbai- 400051 Scrip Code: 540311 Scrip Code- JITFINFRA Sub- Information pursuant to Regulations 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today, i.e., Sept 02, 2026, approved: - 1. The appointment of Dr. Vinita Jha (DIN : 08395714) as an Additional Director in category of Independent Women Director of the Company w.e.f Sept 02, 2026. 2. Ms. Kanika Sharma (DIN: 08936073) has tendered her resignation as a Non- Executive Director of the Company w.e.f Sept 02, 2026.( the letter of resignation received from Ms. Kanika Sharma is enclosed herewith.) The information as required under Regulation 30 read with SEBI Circular no. SEBI Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is attached as ‘Annexure A’ respectively. The Board Meeting commenced at 02:00 P.M. and concluded at 02:30 P.M. This is for your information and record please. Thanking You Yours Faithfully Alok Kumar Company Secretary M- A19819 Details with respect to Regulation 30 read with SEBI Circular no. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 S. No. Particulars Details Details 1. Name of Director Dr. Vinita Jha Ms. Kanika Sharma 2. Reason for change viz. Appointment Resignation appointment, reappointment, resignation, removal, death or otherwise 3. Date of Appointment/Re- 02.09.2026 02.09.2026 appointment/cessation and terms of Appointment/Re- appointment 4. Brief profile (in case of Attached as Annexure-1 NA appointment) 5. Disclosure of relationships There are no inter-se relations NA between directors (in case of between Dr. Vinita Jha and the appointment of a director) other members of the Board. 6. Debarment affirmation Dr. Vinita Jha is not debarred from NA holding the office by virtue of any SEBI Order or any other authority. Annexure-1 DR. VINITA JHA MBBS,MBA (U.K.) A thorough professional, with a decade of senior leadership experience in corporate hospitals, self-motivated to outperform myself, striving for perfection; a thorough people's person with leadership acumen; a unique blend of people management and business skills, enriched with relevant qualifications and experience make me suitable to lead businesses; fortunate to have trudged through ops, P&L management and Clinical Policies Professional Qualification  CCT Psych UK. 2004  MBA, (Cardiff) UK, 2000 - 2002, Human Resource & Marketing  MBBS, Bihar 1996  ISC De Nobili School, Dhanbad 1989  ICSE De Nobili School, Dhanbad 1987 Brief Professional Snapshot:  Senior Vice President - Clinical Directorate - July 2014 - current  Director — Ops, Office of Research, Max Home Health Care, —June 2012 to June2014  General Manager, Ops — Max Hospital, Gurgaon —July 2010 to June 2012  Department Head Max Home Care, Max Health Care, New Delhi, May2009 — June2010  Consultant, Independent Health Consultancy for major corporates in India, 2008 - 2009  Consultant, Advisory role, Max Health Care, New Delhi, 2007  Senior House Officer, Somerset Partnership NHS Trust, UK, 2004 to 2007  Business Manager, Shamrock House, Goole, UK, 2003 to 2004  Research Lead, Gates Foundation & WHO, Bihar from 1997 to 2000